Isoleucine

Isoleucine

SCHEMBL17165641

CC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1.CC[C@H](C)[C@H](N)C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.53
▸ MTOR P42345 2/20 0.53
▸ THRB P10828 1/20 0.53
▸ MDM2 Q00987 1/20 0.53
▸ NCOA1 Q15788 1/20 0.53
▸ NCOA3 Q9Y6Q9 1/20 0.53
▸ P2RY6 Q15077 4/20 0.44
▸ P2RY14 Q15391 2/20 0.44
▸ NT5E P21589 1/20 0.44
▸ GMNN O75496 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ DNMT1 P26358 1/20 0.44
▸ THPO P40225 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ HBB P68871 1/20 0.44
▸ PMP22 Q01453 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoleucine SCHEMBL17165634 1.00 LMNA (0.53) LMNAMTORTHRBMDM2NCOA1
SCHEMBL20459954 0.87 LMNA (0.65) LMNAMTORTHRBMDM2NCOA1
SCHEMBL6397305 0.87 LMNA (0.65) LMNAMTORTHRBMDM2NCOA1
SCHEMBL14946394 0.87 LMNA (0.65) LMNAMTORTHRBMDM2NCOA1
SCHEMBL453447 0.87 LMNA (0.65) LMNAMTORTHRBMDM2NCOA1
SCHEMBL453448 0.87 LMNA (0.65) LMNAMTORTHRBMDM2NCOA1
SCHEMBL14929347 0.87 LMNA (0.65) LMNAMTORTHRBMDM2NCOA1
SCHEMBL20967857 0.87 LMNA (0.65) LMNAMTORTHRBMDM2NCOA1
SCHEMBL20628772 0.87 LMNA (0.65) LMNAMTORTHRBMDM2NCOA1
SCHEMBL17165639 0.86 P2RY6 (0.47) P2RY6P2RY14NT5EP2RY2P2RY4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3151665-A1 METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK Laboratory Corporation of America Holdings (US) 2017-04-12 — — EP disclosed
WO-2015157601-A1 METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK SYNAPDX CORPORATION (US) 2015-10-15 — — WO disclosed
Send feedback